Collaboration yields promising Barriolide therapy Enterothelin EpiEndo Pharmaceuticals, a clinical-stage biopharmaceutical company, and AlveoliX, an innovator in organ-on-chip technology, have announced significant advancements in their […]
In 2022, around 8% of patients survived 30 days after a cardiac arrest New data published by the Out-of-Hospital Cardiac Arrest Outcomes (OHCAO) Registry, based […]
The biodegradable polymer scaffold encourages the body to grow new tissue Researchers at Harefield Hospital and Imperial College London’s (ICL) National Heart and Lung Institute […]